Pirfenidone

CAT:
804-HY-B0673-01
Size:
100 mg
  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: No
Pirfenidone - image 1

Pirfenidone

  • Description :

    Pirfenidone (AMR69) is an antifibrotic agent that attenuates CCL2 and CCL12 production in fibrocyte cells. Pirfenidone has growth-inhibitory effect and reduces TGF-β2 protein levels in human glioma cell lines. Pirfenidone also has anti-inflammatory activities[1][2][3].
  • Product Name Alternative :

    AMR69
  • UNSPSC :

    12352005
  • Hazard Statement :

    H302
  • Target :

    CCR; TGF-beta/Smad
  • Type :

    Reference compound
  • Related Pathways :

    GPCR/G Protein; Immunology/Inflammation; Stem Cell/Wnt; TGF-beta/Smad
  • Applications :

    COVID-19-immunoregulation
  • Field of Research :

    Inflammation/Immunology; Cancer
  • Assay Protocol :

    https://www.medchemexpress.com/Pirfenidone.html
  • Purity :

    99.99
  • Solubility :

    DMSO : ≥ 100 mg/mL|H2O : 12.5 mg/mL (ultrasonic)
  • Smiles :

    O=C1C=CC(C)=CN1C2=CC=CC=C2
  • Molecular Formula :

    C12H11NO
  • Molecular Weight :

    185.23
  • Precautions :

    H302
  • References & Citations :

    [1]Burghardt I, et al. Pirfenidone inhibits TGF-beta expression in malignant glioma cells. Biochem Biophys Res Commun. 2007 Mar 9;354 (2) :542-7.|[2]Nakazato H, et al. A novel anti-fibrotic agent pirfenidone suppresses tumor necrosis factor-alpha at the translational level. Eur J Pharmacol. 2002 Jun 20;446 (1-3) :177-85.|[3]Yang Y, et al. Inhibition of Pirfenidone on TGF-beta2 induced proliferation, migration and epithlial-mesenchymal transitionof human lens epithelial cells line SRA01/04. PLoS One. 2013;8 (2) :e56837.|[4]Inomata M, et al. Pirfenidone inhibits fibrocyte accumulation in the lungs in bleomycin-induced murine pulmonary fibrosis. Respir Res. 2014 Feb 8;15:16.|[5]Brooks D, et al. Limited fibrosis accompanies triple-negative breast cancer metastasis in multiple model systems and is not a preventive target. Oncotarget. 2018 May 4;9 (34) :23462-23481.
  • Shipping Conditions :

    Room Temperature
  • Storage Conditions :

    -20°C, 3 years; 4°C, 2 years (Powder)
  • Scientific Category :

    Reference compound1
  • Clinical Information :

    Launched
  • CAS Number :

    [53179-13-8]